ARK Genomic Revolution ETF Rating $25.95 +2.34 (+9.92%) Closing price 03:59 PM EasternExtended Trading$26.22 +0.27 (+1.03%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings ARK Genomic Revolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.71Holdings in ARKG have an aggregate rating of Moderate Buy based on 432 analyst ratings issued in the past year covering 35 companies (100.0% of the portfolio).ARKG Aggregate Price Target$25.95High Prediction$25.95Average Prediction$25.95Low Prediction$25.95Holdings in ARKG have an aggregate price target of $25.95 and a range of $25.95 to $25.95 covering 35 companies (100.0% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 35 ARKG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.99%TWSTTwist Bioscience$50.45+6.1%2.9208 of 5 stars2.70$51.90 2.9%106.79%RXRXRecursion Pharmaceuticals$6.88+5.4%2.3125 of 5 stars2.40$8.75 27.2%5Gap Up6.41%CRSPCRISPR Therapeutics$41.51+2.4%2.7274 of 5 stars2.47$78.38 88.8%19Short Interest ↑Gap Up5.33%ADPTAdaptive Biotechnologies$7.45+9.4%2.6927 of 5 stars2.75$6.75 -9.4%4Gap Up5.13%NTRANatera$167.46+5.7%2.2485 of 5 stars3.00$160.63 -4.1%164.88%GHGuardant Health$45.13+23.1%3.4436 of 5 stars3.00$40.60 -10.0%15Short Interest ↓News CoverageGap UpHigh Trading Volume4.80%CDNACareDx$22.70+5.9%3.2033 of 5 stars2.57$28.33 24.8%74.68%VCYTVeracyte$43.60+7.4%3.9821 of 5 stars2.67$41.13 -5.7%9News CoveragePositive News4.24%TEMTempus AI$47.64+35.5%2.2026 of 5 stars2.75$56.36 18.3%12Options VolumeNews CoverageGap UpHigh Trading Volume3.85%SDGRSchrödinger$21.33+12.3%2.0853 of 5 stars2.82$32.90 54.2%11News CoveragePositive NewsGap Down3.75%BEAMBeam Therapeutics$24.53+4.7%3.5586 of 5 stars2.92$47.67 94.3%123.72%TXG10x Genomics$16.16+7.2%4.6572 of 5 stars2.53$23.86 47.6%17Analyst Forecast3.16%PSNLPersonalis$5.55+13.5%4.2411 of 5 stars3.00$8.56 54.3%4Gap Up3.08%IONSIonis Pharmaceuticals$32.68+4.0%4.2445 of 5 stars2.68$60.65 85.6%192.93%ARCTArcturus Therapeutics$16.41-2.3%2.5238 of 5 stars3.14$66.75 306.8%7Short Interest ↑Positive News2.89%ACCDAccolade$6.88-0.1%3.7904 of 5 stars2.08$7.55 9.8%13Short Interest ↑2.79%NRIXNurix Therapeutics$19.60+2.4%2.1666 of 5 stars2.94$30.35 54.9%17Analyst Forecast2.61%NTLAIntellia Therapeutics$9.94+4.6%4.6611 of 5 stars2.72$51.06 413.7%182.25%ABSIAbsci$3.22+11.0%2.2135 of 5 stars3.00$8.50 164.0%6Short Interest ↑Gap Down2.14%BFLYButterfly Network$3.90+6.1%1.0295 of 5 stars3.00$3.00 -23.0%1Gap Up1.97%PACBPacific Biosciences of California$1.70+3.7%1.9714 of 5 stars2.50$2.95 73.8%121.78%QSIQuantum-Si$2.44+8.9%2.3952 of 5 stars2.50$3.25 33.2%2Gap Up1.74%ILMNIllumina$141.31+3.4%4.5153 of 5 stars2.70$165.63 17.2%201.61%AMGNAmgen$274.81+1.0%4.8942 of 5 stars2.44$314.91 14.6%27Positive News1.26%VEEVVeeva Systems$223.19+3.0%4.6497 of 5 stars2.63$255.74 14.6%27Positive News1.23%CERSCerus$1.85+3.4%2.5869 of 5 stars2.75$3.63 95.9%41.06%INCYIncyte$73.47+2.1%4.7853 of 5 stars2.35$76.29 3.8%200.97%VRTXVertex Pharmaceuticals$427.89+1.4%4.3126 of 5 stars2.52$490.38 14.6%31Positive News0.84%REGNRegeneron Pharmaceuticals$687.80+0.9%4.6201 of 5 stars2.65$1,015.38 47.6%23News Coverage0.73%MASS908 Devices$3.03+1.7%3.6668 of 5 stars2.50$5.33 76.0%4Analyst ForecastGap Up0.63%PRMEPrime Medicine$2.91+0.7%3.7428 of 5 stars3.10$13.13 351.0%100.61%LABStandard BioTools$1.88+6.2%2.5336 of 5 stars3.00$2.88 52.9%20.54%CMPSCOMPASS Pathways$3.64+4.3%2.8989 of 5 stars3.00$33.60 823.1%6News CoveragePositive News0.38%EXASExact Sciences$54.26+4.9%4.8177 of 5 stars2.94$72.94 34.4%18News Coverage0.23%RPTXRepare Therapeutics$1.24-3.1%2.8106 of 5 stars2.50$7.00 464.5%4News Coverage This page (BATS:ARKG) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
